Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
Authors
Keywords
-
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1869, Issue 6, Pages 166720
Publisher
Elsevier BV
Online
2023-04-15
DOI
10.1016/j.bbadis.2023.166720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The concept of intrinsic versus extrinsic apoptosis
- (2022) Laura Lossi BIOCHEMICAL JOURNAL
- Aptamer-functionalized targeted siRNA delivery system for tumor immunotherapy
- (2022) Haiyin Lv et al. Biomedical Materials
- The DNA-PK inhibitor AZD7648 sensitizes patient derived ovarian cancer xenografts to pegylated liposomal doxorubicin and olaparib preventing abdominal metastases
- (2022) Alessia Anastasia et al. MOLECULAR CANCER THERAPEUTICS
- How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme
- (2022) Mehdi Sanati et al. Pharmacological Reports
- Novel DNA Aptamer for CYP24A1 Inhibition with Enhanced Antiproliferative Activity in Cancer Cells
- (2022) Madhu Biyani et al. ACS Applied Materials & Interfaces
- Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance
- (2022) Yanyan Ma et al. ANALYTICAL CHEMISTRY
- Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
- (2022) Hongyi Chen et al. BIOMATERIALS
- Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
- (2022) Verona Buocikova et al. BIOMEDICINE & PHARMACOTHERAPY
- Should mutant TP53 be targeted for cancer therapy?
- (2022) Zilu Wang et al. CELL DEATH AND DIFFERENTIATION
- Expression of Cytochrome P450 Enzymes in Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Possible Role in Carcinogenesis and Treatment Response
- (2022) Carmen Torres-Zárate et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Recent advances in nanotechnology based combination drug therapy for skin cancer
- (2022) Shweta Kumari et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells
- (2022) Rong Chen et al. LEUKEMIA
- A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
- (2022) Yi-Ying Wu et al. Molecular Therapy-Nucleic Acids
- Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer
- (2022) Hyeon Woo Kim et al. Cancers
- Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells
- (2022) Sergei Boichuk et al. Biomedicines
- Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy
- (2022) Yuhong Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics
- (2022) Prashant Kesharwani et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress
- (2022) Mehdi Sanati et al. JOURNAL OF CONTROLLED RELEASE
- Current trends in stimuli-responsive nanotheranostics based on metal–organic frameworks for cancer therapy
- (2022) Fatemeh Oroojalian et al. Materials Today
- Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα
- (2022) Elizabeth G. Gibson et al. Symmetry-Basel
- Anti-TGF-β1 aptamer enhances therapeutic effect of tyrosine kinase inhibitor, gefitinib, on non-small cell lung cancer in xenograft model
- (2022) Masaki Takahashi et al. Molecular Therapy-Nucleic Acids
- Aptamers as Theragnostic Tools in Prostate Cancer
- (2022) Carlos David Cruz-Hernández et al. Biomolecules
- AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer
- (2022) Nashmin Fayazi Hosseini et al. BIOMEDICINE & PHARMACOTHERAPY
- MLH1 hypermethylation predicts poor outcomes with pembrolizumab in recurrent endometrial cancer (087)
- (2022) Lindsay Borden et al. GYNECOLOGIC ONCOLOGY
- Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
- (2022) Simona Camorani et al. Pharmaceutics
- Galactose engineered nanocarriers: Hopes and hypes in cancer therapy
- (2022) Mahak Fatima et al. EUROPEAN POLYMER JOURNAL
- Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC
- (2022) Pramod Kumar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair
- (2021) Gloria Ciniero et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability
- (2021) Sumeet Nayak et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
- (2021) Wanxiao Sun et al. JOURNAL OF CONTROLLED RELEASE
- Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo
- (2021) Ting Li et al. MOLECULES
- Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib
- (2021) Ji An Hwang et al. Translational Cancer Research
- Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell–Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer
- (2021) Qianqian Guo et al. ACS Applied Materials & Interfaces
- Regulatory T cells in ischemic stroke
- (2021) Hong-yun Wang et al. ACTA PHARMACOLOGICA SINICA
- Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions
- (2021) Abolfazl Maghrouni et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
- (2021) Emily L. Giddings et al. Nature Communications
- Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer
- (2021) Zhefeng Li et al. Nucleic Acid Therapeutics
- SELEX: Critical factors and optimization strategies for successful aptamer selection
- (2021) Michael Kohlberger et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
- (2021) Lingyue Gao et al. DRUG RESISTANCE UPDATES
- Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery
- (2021) Vanshikha Singh et al. EUROPEAN POLYMER JOURNAL
- Tumor-Specific Delivery of 5-Fluorouracil–Incorporated Epidermal Growth Factor Receptor–Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models
- (2021) Ujjwal M. Mahajan et al. GASTROENTEROLOGY
- Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer
- (2021) Mahsa Shahriari et al. JOURNAL OF CONTROLLED RELEASE
- Aptamers: Cutting edge of cancer therapies
- (2021) Sarah Shigdar et al. MOLECULAR THERAPY
- Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells
- (2021) Shelby B. Smiley et al. PHARMACEUTICAL RESEARCH
- Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance
- (2021) Amir Barzegar Behrooz et al. Drug Delivery and Translational Research
- Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
- (2021) Christiana M. Neophytou et al. Cancers
- Vorinostat triggers miR-769–5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer
- (2021) Weiyu Dai et al. CANCER LETTERS
- Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
- (2021) Liang Dai et al. CELL PROLIFERATION
- Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras
- (2021) Yuying Jiao et al. NUCLEAR MEDICINE AND BIOLOGY
- Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer
- (2021) Yan Li et al. ONCOGENE
- Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy
- (2021) Chang Yang et al. Journal of Materials Chemistry B
- FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
- (2021) Jakub Szymczyk et al. Cancers
- Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation
- (2021) Mounira Chalabi-Dchar et al. Cancers
- Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer
- (2021) Erica Yada et al. Biomedicines
- Targeting Drug Chemo-Resistance in Cancer Using Natural Products
- (2021) Wamidh H. Talib et al. Biomedicines
- Protective role of natural products in glioblastoma multiforme: A focus on nitric oxide pathway.
- (2020) Amir R. Afshari et al. CURRENT MEDICINAL CHEMISTRY
- Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)
- (2020) Chunlong Zhao et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
- (2020) Li Peng et al. International Journal of Nanomedicine
- Targeting Ephrin Receptor Tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells
- (2020) Alessandra Affinito et al. Molecular Therapy-Nucleic Acids
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
- (2020) Fengjiao Yao et al. International Journal of Nanomedicine
- DNA Damage/Repair Management in Cancers
- (2020) Jehad F. Alhmoud et al. Cancers
- Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
- (2020) Carla Lucia Esposito et al. Cancers
- Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
- (2020) Yougan Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- The current state of potential therapeutic modalities for glioblastoma multiforme: a clinical review
- (2020) Elmira Mohtashami et al. CURRENT DRUG METABOLISM
- Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a systematic review
- (2020) Letícia Madureira Pacholak et al. MOLECULAR BIOLOGY REPORTS
- Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling
- (2020) Hui Yang et al. ONCOGENE
- Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles
- (2020) Ruifeng Wu et al. Drug Design Development and Therapy
- Construction of Aptamer‐siRNA Chimera/PEI/5‐FU/Carbon Nanotube/Collagen Membranes for the Treatment of Peritoneal Dissemination of Drug‐Resistant Gastric Cancer
- (2020) Wen Chen et al. Advanced Healthcare Materials
- Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer
- (2020) Santosh Kumar Singh et al. Cells
- Aptamer-Peptide Conjugates as Targeted Chemosensitizers for Breast Cancer Treatment
- (2020) Yan Tan et al. ACS Applied Materials & Interfaces
- Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
- (2020) Zongguang Tai et al. International Journal of Nanomedicine
- Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo
- (2020) Negin Ghandhariyoun et al. LIFE SCIENCES
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Circulating Tumor Cells Develop Resistance to TRAIL-Induced Apoptosis Through Autophagic Removal of Death Receptor 5: Evidence from an In Vitro Model
- (2019) Julianne Twomey et al. Cancers
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
- (2019) Chodimella Chandrasekhar et al. Scientific Reports
- Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
- (2019) Michael Steurer et al. HAEMATOLOGICA
- ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells
- (2019) Shirin Hashemitabar et al. JOURNAL OF BIOSCIENCES
- Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer
- (2019) Joo Han Lee et al. MOLECULAR BIOLOGY REPORTS
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Clonal selection with Ras pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia
- (2019) Christine M. McMahon et al. Cancer Discovery
- Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer
- (2019) Changlei Xi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
- (2019) Jessica L. Wojtaszek et al. CELL
- Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
- (2019) Silvia Pietrobono et al. Frontiers in Genetics
- Fibroblast Growth Factor Receptor Functions in Glioblastoma
- (2019) Ana Jimenez-Pascual et al. Cells
- A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer
- (2019) Xin Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma
- (2019) Wei Fu et al. ACS Applied Materials & Interfaces
- Aptamer-Based Erythrocyte-Derived Mimic Vesicles Loaded with siRNA and Doxorubicin for the Targeted Treatment of Multidrug-Resistant Tumors
- (2019) Tengfei Wang et al. ACS Applied Materials & Interfaces
- EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer
- (2019) Yuyu Zhao et al. MOLECULAR PHARMACEUTICS
- Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
- (2019) Pierre Autin et al. Cancers
- Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells
- (2019) Qingshan Pan et al. ACS Applied Materials & Interfaces
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein
- (2019) Hui Li et al. Molecular Therapy-Nucleic Acids
- Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer
- (2018) Tingting Lv et al. Acta Biomaterialia
- Aptamer chemistry
- (2018) Pascal Röthlisberger et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
- (2018) Gang Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells
- (2018) Junko Hamamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting forkhead box M1 transcription factor in breast cancer
- (2018) Ruth M. O'Regan et al. BIOCHEMICAL PHARMACOLOGY
- Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites
- (2018) Fan Xu et al. BIOMATERIALS
- Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events
- (2018) Maurizio Battaglia Parodi et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy
- (2018) Parvin Zamani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mechanisms of receptor tyrosine kinase activation in cancer
- (2018) Zhenfang Du et al. Molecular Cancer
- Aptamers in the Therapeutics and Diagnostics Pipelines
- (2018) Harleen Kaur et al. Theranostics
- Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2 + Breast Cancer
- (2018) Xiaolin Yu et al. Molecular Therapy-Nucleic Acids
- Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
- (2018) Xingmei Zhang et al. Molecular Therapy-Nucleic Acids
- Mutational processes shape the landscape of TP53 mutations in human cancer
- (2018) Andrew O. Giacomelli et al. NATURE GENETICS
- An RNA toolbox for cancer immunotherapy
- (2018) Fernando Pastor et al. NATURE REVIEWS DRUG DISCOVERY
- Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411
- (2018) Vivek R. Sharma et al. CANCER INVESTIGATION
- Aptamer Based Targeted Drug Delivery Systems: Current Potential and Challenges
- (2018) Fen He et al. CURRENT MEDICINAL CHEMISTRY
- DNA Methyltransferase Inhibitors and Their Therapeutic Potential
- (2018) Zehao Zhou et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
- (2018) Hongyan Wang et al. MEDICAL SCIENCE MONITOR
- Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
- (2017) David Powell et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
- (2017) Shuaijian Ni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer
- (2017) Pengchao Sun et al. International Journal of Nanomedicine
- Nanoparticles as new tools for inhibition of cancer angiogenesis
- (2017) Nasser Hashemi Goradel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study
- (2017) H Ludwig et al. LEUKEMIA
- Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
- (2017) Yoshiteru Ohata et al. MOLECULAR CANCER THERAPEUTICS
- Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
- (2017) Xiaolong Huang et al. World Journal of Surgical Oncology
- Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase
- (2017) Xuan Wang et al. Oncotarget
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth
- (2017) Sorah Yoon et al. Molecular Therapy-Nucleic Acids
- Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
- (2017) Pinar Kanlikilicer et al. Molecular Therapy-Nucleic Acids
- Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
- (2017) Daniel V. Brown et al. PLoS One
- Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
- (2017) Hadi AlShamaileh et al. Scientific Reports
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
- (2016) Angelika Dlugosz et al. CURRENT PHARMACEUTICAL DESIGN
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells
- (2016) Hyosook Jeong et al. MACROMOLECULAR BIOSCIENCE
- Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells
- (2016) David D. Dickey et al. METHODS
- Extracellular ATP a New Player in Cancer Metabolism: NSCLC Cells Internalize ATP In Vitro and In Vivo Using Multiple Endocytic Mechanisms
- (2016) Y. Qian et al. MOLECULAR CANCER RESEARCH
- Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
- (2016) Sorah Yoon et al. MOLECULAR THERAPY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT
- (2016) Zhuxin Wei et al. OncoTargets and Therapy
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Long non-coding RNAs in anti-cancer drug resistance
- (2016) Qin-nan Chen et al. Oncotarget
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
- (2015) Yeh-Hsing Lao et al. ACS Nano
- Chemical inhibitor targeting the replication protein A–DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer
- (2015) Akaash K. Mishra et al. BIOCHEMICAL PHARMACOLOGY
- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
- (2015) Claudia Fiorini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
- (2015) Nianxi Zhao et al. BIOMATERIALS
- Therapeutic aptamers: developmental potential as anticancer drugs
- (2015) Ji Won Lee et al. BMB Reports
- ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy
- (2015) Haigang Cui et al. CURRENT DRUG TARGETS
- Cancer immunotherapy via nucleic acid aptamers
- (2015) Mostafa Khedri et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance
- (2015) Zi-Xian Liao et al. JOURNAL OF CONTROLLED RELEASE
- A Highlight of Recent Advances in Aptamer Technology and Its Application
- (2015) Hongguang Sun et al. MOLECULES
- Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine
- (2015) Chong-chong Gao et al. TUMOR BIOLOGY
- Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
- (2015) Simona Camorani et al. Oncotarget
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
- (2015) David Porciani et al. Molecular Therapy-Nucleic Acids
- Targeted Delivery of Doxorubicin Using a Colorectal Cancer-Specific ssDNA Aptamer
- (2015) Wanming Li et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- Emerging strategies to overcome resistance to endocrine therapy for breast cancer
- (2014) M. Firdos Ziauddin et al. CANCER AND METASTASIS REVIEWS
- Multiple roles of extracellular fibroblast growth factors in lung cancer cells
- (2014) TAKAHIRO SUZUKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review)
- (2014) L. MAGADOUX et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy
- (2014) Xiaohong Bi et al. JOURNAL OF BIOMEDICAL OPTICS
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Glutathione and glutathione peroxidase expression in breast cancer: An immunohistochemical and molecular study
- (2013) BRUNA VICTORASSO JARDIM et al. ONCOLOGY REPORTS
- Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
- (2013) B. Gibert et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China
- (2013) Jie Ge et al. PLoS One
- Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics
- (2013) Yewei Liu et al. Protein & Cell
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera
- (2012) Nenghui Liu et al. CANCER INVESTIGATION
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- Contribution of intracellular ATP to cisplatin resistance of tumor cells
- (2012) Verena Schneider et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells
- (2011) Yun-Hee Kim et al. CANCER LETTERS
- HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines
- (2011) Miki Watanabe et al. CANCER LETTERS
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
- (2011) Amalia Azzariti et al. CURRENT DRUG METABOLISM
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
- (2011) Devika Gajria et al. Expert Review of Anticancer Therapy
- Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells
- (2010) D S Mern et al. BRITISH JOURNAL OF CANCER
- The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell lines
- (2010) Ravi P. Sahu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
- (2010) S. Dangi-Garimella et al. CANCER RESEARCH
- Simultaneous electrochemical detection of both PSMA (+) and PSMA (−) prostate cancer cells using an RNA/peptide dual-aptamer probe
- (2010) Kyoungin Min et al. CHEMICAL COMMUNICATIONS
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Cancer stem cell markers in common cancers – therapeutic implications
- (2008) Thomas Klonisch et al. TRENDS IN MOLECULAR MEDICINE
- RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin
- (2007) Jing Mi et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search